RESEARCH-USE BIOSIMILAR ANTIBODY
Inebilizumab
Monoclonal antibody · IgG1
Inebilizumab is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research.
TARGETCD19
YMonoclonal antibody
CATALOGSC-BS-475
CATALOG NUMBERSC-BS-475
MOLECULAR WEIGHTApprox. 150 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Inebilizumab is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research.
Inebilizumab is a recombinant research-use antibody directed against CD19.